KR100508079B1 - 코로나바이러스 및 유해 미생물의 증식을 억제하는 신규한 내산성 프로바이오틱 미생물 루코노스톡 메센테로이즈 프로바이오-62 - Google Patents

코로나바이러스 및 유해 미생물의 증식을 억제하는 신규한 내산성 프로바이오틱 미생물 루코노스톡 메센테로이즈 프로바이오-62 Download PDF

Info

Publication number
KR100508079B1
KR100508079B1 KR1020040039417A KR20040039417A KR100508079B1 KR 100508079 B1 KR100508079 B1 KR 100508079B1 KR 1020040039417 A KR1020040039417 A KR 1020040039417A KR 20040039417 A KR20040039417 A KR 20040039417A KR 100508079 B1 KR100508079 B1 KR 100508079B1
Authority
KR
South Korea
Prior art keywords
62new
probio
suppress
growth
pathogenic microorganisms
Prior art date
Application number
KR1020040039417A
Other languages
English (en)
Inventor
박용하
이인선
김홍익
김철중
Original Assignee
주식회사 프로바이오닉
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 프로바이오닉 filed Critical 주식회사 프로바이오닉
Priority to KR1020040039417A priority Critical patent/KR100508079B1/ko
Application granted granted Critical
Publication of KR100508079B1 publication Critical patent/KR100508079B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
KR1020040039417A 2004-06-01 2004-06-01 코로나바이러스 및 유해 미생물의 증식을 억제하는 신규한 내산성 프로바이오틱 미생물 루코노스톡 메센테로이즈 프로바이오-62 KR100508079B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020040039417A KR100508079B1 (ko) 2004-06-01 2004-06-01 코로나바이러스 및 유해 미생물의 증식을 억제하는 신규한 내산성 프로바이오틱 미생물 루코노스톡 메센테로이즈 프로바이오-62

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040039417A KR100508079B1 (ko) 2004-06-01 2004-06-01 코로나바이러스 및 유해 미생물의 증식을 억제하는 신규한 내산성 프로바이오틱 미생물 루코노스톡 메센테로이즈 프로바이오-62

Publications (1)

Publication Number Publication Date
KR100508079B1 true KR100508079B1 (ko) 2005-08-18

Family

ID=37304188

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020040039417A KR100508079B1 (ko) 2004-06-01 2004-06-01 코로나바이러스 및 유해 미생물의 증식을 억제하는 신규한 내산성 프로바이오틱 미생물 루코노스톡 메센테로이즈 프로바이오-62

Country Status (1)

Country Link
KR (1) KR100508079B1 (ko)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100808956B1 (ko) 2006-05-08 2008-03-04 조선대학교산학협력단 김치로부터 분리된 유산균 및 이로부터 얻어지는 엑소폴리사카라이드
KR101194798B1 (ko) 2011-06-08 2012-10-25 목포대학교산학협력단 김치로부터 분리된 유산균 및 그의 용도
KR101381547B1 (ko) 2007-10-19 2014-04-17 대상에프앤에프 주식회사 병원성 세균의 생육을 억제하는 김치에서 분리한 신규류코노스톡 메센트로이드 및 이의 용도

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100808956B1 (ko) 2006-05-08 2008-03-04 조선대학교산학협력단 김치로부터 분리된 유산균 및 이로부터 얻어지는 엑소폴리사카라이드
KR101381547B1 (ko) 2007-10-19 2014-04-17 대상에프앤에프 주식회사 병원성 세균의 생육을 억제하는 김치에서 분리한 신규류코노스톡 메센트로이드 및 이의 용도
KR101194798B1 (ko) 2011-06-08 2012-10-25 목포대학교산학협력단 김치로부터 분리된 유산균 및 그의 용도

Similar Documents

Publication Publication Date Title
EP1859022A4 (en) NEW SAFETY TOLERANT LACTOBACILLUS SAKEI PROBIO-65 WITH THE CAPACITY TO SUPPORT GROWTH-BASED MICRO-ORGANISMS AND ANTI-ALLERGIC EFFECTS
AU2003247193A1 (en) Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
AU2003303894A1 (en) Inactivated probiotic bacteria and methods of use thereof
AU305551S (en) Bottle
AU305158S (en) Bottle
AU305552S (en) Bottle
EP1909850A4 (en) RNAI MODULATION OF RHO-A GENE AND USES THEREOF
PL1773361T3 (pl) Kompozycje oparte na bakteriach probiotycznych i ich zastosowanie w profilaktyce i/lub leczeniu patologii i/lub zakażeń układu oddechowego oraz poprawie funkcji jelit
ZA200800978B (en) Food products comprising probiotic micro-organisms and antibodies
PL1981516T3 (pl) Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom
AU317418S (en) Bottle
EP1812023B8 (en) Lactic acid bacteria as probiotic strains and compositions containing same
PT1753440E (pt) Forma de administração oral contendo bactérias probióticas
AU305027S (en) Bottle
AU314321S (en) Mug
AU320296S (en) Bottle
ZA200900235B (en) Prevention and treatment of otitis media with non-pathogenic bacterial strains
MX2009003260A (es) Probioticos para el uso en la reduccion de la incidencia y duracion de la enfermedad.
AU316120S (en) Bottle
KR100508079B1 (ko) 코로나바이러스 및 유해 미생물의 증식을 억제하는 신규한 내산성 프로바이오틱 미생물 루코노스톡 메센테로이즈 프로바이오-62
KR100508109B1 (ko) 코로나바이러스 및 유해 미생물의 증식을 억제하는 신규한 내산성 프로바이오틱 미생물 락토바실러스 사케이 프로바이오-61
GB0720997D0 (en) Methods of altering gene expression and methods of treatment utilizing same
EP1724341A4 (en) NOVEL, TASTE MANAGEMENT MODIFYING PEPTIDE NAS, ITS DNA AND ITS USE
EP1841464A4 (en) RNAI MODULATION OF NOGO-L OR NOGO-R GENE AND USES THEREOF
PL373179A1 (pl) Zastosowanie kwasu L-askorbinowego w jogurtach, zwłaszcza do stabilizacji rozwoju bakterii jogurtowych i probiotycznych

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
J202 Request for trial for correction [limitation]
J301 Trial decision

Free format text: TRIAL DECISION FOR CORRECTION REQUESTED 20060718

Effective date: 20070530

FPAY Annual fee payment

Payment date: 20110811

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee